Healthcare Investors lagged its benchmark as biotech faced regulatory hurdles and market rotation. Read the full analysis for ...
Carlos Augusto has never been the poster boy. He doesn’t seek the spotlight, doesn’t raise his voice, doesn’t make noise. And ...